RxDoctor Payments Data

Paul Vanek, MD

Plastic and Reconstructive Surgery · Mentor, OHNPI 1730256967

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (49.1%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Solta Medical, A Division Of Bausch Health US, LLC accounts for 74.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $47,597 and has fallen 86.2% since, to $6,555 in 2025. Among plastic and reconstructive surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$91,312in general payments, 2019–2025

Across 124 payments — averaging $736.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Solta Medical, A Division Of Bausch Health US, LLC$68K
  • Apyx Medical Corporation$17K
  • AbbVie$4K
  • Sientra, Inc.$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$859
  • Revance Therapeutics, Inc.$219
  • plus $485 from 8 others
$813in research payments, 2019–2025

Across 2 payments — averaging $406.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sientra, Inc.$813

What the payments were for

  • Consulting fees$31,40034%
  • Speaking & faculty fees$11,29212%
  • Travel & lodging$44,85449%
  • Food & beverage$3,7664%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$91,312 in reported general payments places this provider in the 95th percentile of 78 plastic and reconstructive surgery providers in Ohio.

See all plastic and reconstructive surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$34,153
Medicare patients
52
Services billed
223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron Hcl18$313
Cephalexin22$142
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha12$138
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$45

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Mentor

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →